News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Genentech, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
BioForest
Genentech Reveals Their Greatest Source of Who They Hire
January 7, 2015
·
2 min read
Business
23andMe, Genentech Forge $60 Million Parkinson’s Research Deal
January 6, 2015
·
2 min read
Business
Phylogica Ltd. Grabs $142 Million Deal With Genentech
December 22, 2014
·
1 min read
Drug Development
FDA Breakthrough Status For Genentech’s Lucentis
December 16, 2014
·
2 min read
Business
Gilead Sciences, Inc. Poaches Genentech Exec To Head Cancer Drug Program
December 15, 2014
·
3 min read
Policy
Genentech Submits NDA For Skin Cancer Med Cobimetinib
December 15, 2014
·
2 min read
Business
Genentech’s R&D Chief To Retire; Small Molecule Head Takes Over Top Spot
December 12, 2014
·
2 min read
Policy
Doctors Who Promote More Expensive Eye Drug Are Among The Highest-Paid Genentech Consultants
December 9, 2014
·
2 min read
Biotech Bay
Genentech Defends Supply Shift For Top Cancer Drugs
November 25, 2014
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Genentech Announces Positive Phase II Results for Petrelintide, an Amylin Analog Developed for People Living With Overweight and Obesity
March 5, 2026
·
6 min read
Press Releases
Genentech’s Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1)
March 2, 2026
·
14 min read
Press Releases
Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 25, 2026
·
22 min read
Press Releases
Genprex Strengthens Intellectual Property Portfolio with Japanese and EU Patents for Reqorsa® Gene Therapy in Combination with Immunotherapies to Treat Cancer
February 23, 2026
·
7 min read
Press Releases
FDA Approves Genentech’s Venclexta® Plus Acalabrutinib Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia
February 20, 2026
·
17 min read
Press Releases
FDA Accepts New Drug Application for Genentech’s Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer
February 20, 2026
·
8 min read
Press Releases
U.S. Food and Drug Administration (FDA) Approves Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL)
February 20, 2026
·
13 min read
Press Releases
FDA accepts New Drug Application for Roche’s giredestrant in ESR1-mutated, ER-positive advanced breast cancer
February 20, 2026
·
13 min read
Press Releases
Genentech Announces Positive Phase III Results for Gazyva in Primary Membranous Nephropathy, Marking a Significant Milestone in This Autoimmune Disease
February 16, 2026
·
12 min read
Press Releases
Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)
February 9, 2026
·
17 min read
